Harrow Health (HROW) reported Q3 EPS of ($0.24), $0.23 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $22.8 million versus the consensus estimate of $23.14 million.
Harrow Health (HROW) reported Q3 EPS of ($0.24), $0.23 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $22.8 million versus the consensus estimate of $23.14 million.